Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy

NCT02262832 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

NIH

Sponsor class

Conditions

Lipodystrophy
Diabetes
Hyperlipidemia

Interventions

DRUG: Metreleptin

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)